Advertisement

Topics

IP Explained: Why patents are so critical to biopharmaceutical innovation

10:00 EDT 16 Apr 2019 | PhRMA

Today, we are excited to launch our new IP Explained Catalyst series, where each week we’ll break down critical components of the intellectual property (IP) system and the important role it plays in encouraging biopharmaceutical research and development (R&D). We are kicking things off today by looking at patents – the lifeblood of biopharmaceutical innovation.

Original Article: IP Explained: Why patents are so critical to biopharmaceutical innovation

NEXT ARTICLE

More From BioPortfolio on "IP Explained: Why patents are so critical to biopharmaceutical innovation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...